CANARIABIO Inc. announced a private placement of 974,468 common shares at a price of KRW 5,131 for the gross proceeds of KRW 4,999,995,308 on December 20, 2023. The transaction will include participation from returning investor, CANARIABIO M Inc. The transaction has been approved by the shareholders of the company. The transaction is expected to close on December 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
994 KRW | +8.52% | -.--% | -80.70% |
Mar. 29 | CANARIABIO Inc.(KOSDAQ:A016790) dropped from S&P Global BMI Index | CI |
Jan. 24 | Quest PharmaTech Inc. Says Oregovomab Phase III Clinical Study Fails Futility Analysis | MT |
1st Jan change | Capi. | |
---|---|---|
-80.70% | 137M | |
+12.98% | 11.62B | |
+0.32% | 5.71B | |
+5.47% | 5.41B | |
+3.06% | 4.51B | |
-19.30% | 2.71B | |
-18.80% | 1.19B | |
-16.85% | 960M | |
-11.21% | 924M | |
+22.38% | 871M |
- Stock Market
- Equities
- A016790 Stock
- News CANARIABIO Inc.
- CANARIABIO Inc. announced that it expects to receive KRW 4.999995308 billion in funding from CANARIABIO M Inc.